Background: Microalbuminuria (MA) and low-grade inflammation constitute emerging markers of subclinical atherosclerosis. We investigated whether urinary albumin excretion, expressed as the albumin-to-creatinine ratio (ACR), is associated with high sensitivity C-reactive protein (hs-CRP), interleukin (IL)-18, and soluble CD40 ligand (sCD40L), in hypertensive subjects.
A t present, microalbuminuria (MA) is recognized not only as an indicator of early renal dysfunction but also as a surrogate of the subclinical atherosclerotic burden. 1 Moreover, increased urinary albumin excretion constitutes a marker of target organ damage in essential hypertension, including unfavorable alterations of left ventricular geometry, increased intima-media thickness of the carotid artery, and augmented arterial stiffness. [1] [2] [3] [4] [5] Because of these factors, there is an alteration of the clinical positioning of MA in the new guidelines and diagnostic algorithms. 6, 7 In an attempt to assess global risk in essential hypertensives, increasing attention is paid to the identification of the critical proinflammatory pathways involved in the gamut of mechanisms associated with subclinical atherosclerotic disease. 8, 9 Apart from established markers of systemic inflammation like high sensitivity C-reactive protein (hs-CRP), there are several other molecules that reflect potential alternative axis of inflammatory activation. 9 -16 More specifically, both soluble CD40 ligand (sCD40L) and interleukin (IL)-18, promote a wide range of atherogenic effects in various domains of the vasculature. 10 -16 The possible associations between MA and low-grade inflammation may provide a new insight into the pathophysiologic mechanisms linking early renal impairment with elevated cardiovascular risk. 1, [17] [18] [19] [20] On the basis of these observations, we examined whether urinary albumin excretion, expressed as the albumin-to-creatinine ratio (ACR), is associated with hs-CRP, IL-18, and sCD40L in newly diagnosed nondiabetic male essential hypertensive subjects.
Methods

Study Population
The study population consisted of 149 consecutive men with newly diagnosed (within the past 2 years) untreated stage I-II essential hypertension, aged between 30 and 65 years, who were referred to the outpatient hypertension unit within a period of 6 months. 6 Secondary forms of hypertension were excluded, according to established diagnostic methods. 6, 7 Exclusion criteria included heart failure, atherosclerotic cardiovascular disease, diabetes mellitus or glucose intolerance, familial hypercholesterolemia, augmented serum creatinine concentration or overt proteinuria, and any other clinically significant concurrent medical conditions. None of the participants had any clinical and laboratory evidence of inflammation or underwent any medical or dental treatment during the past month before entry into the study. Moreover, to enhance the robustness of the findings, we limited analyses to nonsmokers and to subjects who had a body mass index (BMI) of less than 30 kg/m 2 . Finally, 108 essential hypertensives fulfilling all these inclusion criteria were selected for participation.
The study protocol complies with the Declaration of Helsinki and was approved by our institutional ethics committee and all participants gave written informed consent.
Procedures
Office blood pressure (BP) measurements were obtained, according to the recent guidelines. 6, 7 In all subjects, ACR was determined as the average of two nonconsecutive overnight spot urine samples by using a quantitative assay (DCA 2000, Bayer Diagnostics Europe, Dublin, Ireland), with a coefficient of variation of 2.8%. 21, 22 Venous blood samples were obtained between 8:00 AM and 9:00 AM after an overnight fast and 15 min of supine rest for the estimation of lipid levels, fasting glucose, hemoglobin A 1c , plasma hs-CRP, IL-18, and sCD40L. Plasma levels of hs-CRP were assessed using validated high-sensitivity assay (Dade Behring N High Sensitivity CRP Assay, Marburg, Germany) according to the recommendations of the American Heart Association 8 with a coefficient of variation of 3.6%. More specifically, to account for the intraindividual variability of hs-CRP values, 8 two blood samples were obtained from each subject 2 weeks apart and averaged. Baseline plasma sCD40L levels were estimated by ELISA (Bender MedSystems, Austria), as previously described, 10, 11 with a coefficient of variation of 4.0%. In addition, serum IL-18 was measured with an ELISA method (Biosource International, Nivelles, Belgium), with a coefficient of variation of 6%.
All participants underwent echocardiographic examination, by a senior echocardiographer, who was blind to the clinical status of the examined subject, in line with the recommendations of the American Society of Echocardiography.
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Statistical Analysis
Data are expressed as mean values Ϯ SD. Significant differences between the study groups were determined using the Student independent samples t test or the 2 test where appropriate. Relations between variables were determined by linear regression analysis. Stepwise multiple regression analysis was applied to test the independent relation of ACR, with demographic and laboratory variables. An analysis of covariance was performed to detect significant differences of hs-CRP between the group of microalbuminurics and the group of normoalbuminurics, after the adjustment for a number of covariates. All tests were considered to be significant at the level of P Ͻ .05.
Results
On the basis of the ACR the study population (n ϭ 108) was divided into microalbuminurics (ACR ϭ 30 to 300 mg/g) (n ϭ 28) and normoalbuminurics (ACR Ͻ30 mg/g) (n ϭ 80). Microalbuminuric compared to normoalbuminuric subjects, were older, had greater BMI, longer duration of essential hypertension (1.6 Ϯ 0.2 v 0.6 Ϯ 0.4 years, P ϭ .026), higher systolic BP values (Table 1) , greater left ventricular mass index (114 Ϯ 15 v 100 Ϯ 18 g/m 2 , P ϭ .031) and relative wall thickness (0.44 Ϯ 0.06 v 0.39 Ϯ 0.03, P ϭ .01). In addition, microalbuminurics as compared to normoalbuminurics were characterized by significantly greater levels hs-CRP concentrations (2.55 Ϯ 1.18 v 1.45 Ϯ 0.52 mg/L, P Յ .0001), whereas these two groups did not differ regarding fasting glucose, hemoglobin A 1c , lipid values, IL-18 (245 Ϯ 87 v 241 Ϯ 73 pg/mL, P ϭ .367), and sCD40L levels (2.46 Ϯ 0.8 v 2.41 Ϯ 0.4 ng/mL, P ϭ .184) ( Table 2) .
Correlations
There was a positive correlation of ACR with age (r ϭ 0.525, P Ͻ .0001), BMI (r ϭ 0.482, P Ͻ .0001), systolic BP (r ϭ 0.296, P Ͻ .001), total cholesterol (r ϭ 0.485, P Ͻ .0001), and hs-CRP (r ϭ 0.623, P Ͻ .0001). In addition, the hs-CRP exhibited positive relationships with BMI (r ϭ 0.235, P ϭ .036), waist-to-hip ratio (r ϭ 0.270, P ϭ .018), duration of hypertension (r ϭ 0.563, P Ͻ .0001), systolic BP (r ϭ 0.333, P ϭ .003), total cholesterol (r ϭ 0.277, P ϭ .015), and low-density lipoprotein (r ϭ 0.319, P ϭ .006). Regarding IL-18, it was only negatively related with HDL (r ϭ 0.245, P ϭ .04), whereas sCD40L was not associated with any of the evaluated demographic and laboratory parameters.
When multiple linear regression analysis was performed in the study group, with the ACR as the dependent variable and demographic and laboratory parameters as independent variables, it was revealed that age, BMI, systolic BP, total cholesterol, and hs-CRP were significant independent predictors of the ACR (Table 3) . By applying analysis of covariance, it was shown that hs-CRP levels were significantly different between the normoalbuminuric and microalbuminuric group, after adjusting for age, BMI, systolic BP, total cholesterol, IL-18, and sCD40L levels (P Ͻ .05).
Discussion
The main finding of our study is that urinary albumin excretion, expressed as the ACR, exhibits a close association with hs-CRP, but not with IL-18 and sCD40L in newly diagnosed male essential hypertensive patients. Consequently, although MA is accompanied by heightened levels of an established inflammatory marker, such as hs-CRP, both IL-18 and sCD40L concentrations are not increased in the same setting.
In line with recently reported data, 20 we showed that in the specific clinical setting of untreated and nondiabetic essential hypertension, male subjects with MA compared to those with normal ACR values are characterized by higher levels of hs-CRP. This could be attributed to the fact that subclinical inflammation by causing injury to the kidney may directly alter glomerular function, leading to the development of MA. 1, [17] [18] [19] [20] Alternatively, increased ACR and elevated levels of low-grade inflammatory markers may simply be two facets of the same underlying biological mechanism that is associated with diffuse atherosclerotic disease.
In an attempt to shed more light on the inter-relationships between early renal dysfunction and alternative cascades of proinflammatory activation in essential hypertensives, we reported for the first time that microalbuminurics as compared to normoalbuminurics exhibited no difference in sCD40L and IL-18 values. In previous works, high levels of sCD40L are associated with the presence of high-risk atherosclerotic lesions in elderly subjects with carotid atherosclerosis, 12 and higher concentrations of IL-18 mRNA are identified in unstable atherosclerotic plaques, 16 denoting the interdependencies of these cytokines with diffuse vascular disease. 10 -16 It could be supported that the potential sources for sCD40L (ie, T-lymphocytes, mononuclear phagocytes, and endothelial cells) are perhaps not stimulated up to a sufficient degree in the microalbuminuric state of nondiabetic essential hypertension, whereas Hb A 1c ϭ hemoglobin A 1c ; BMI ϭ body mass index; ACR ϭ albumin-to-creatinine ratio; hs-CRP ϭ high-sensitivity C-reactive protein; IL-18 ϭ interleukin-18; sCD40L ϭ soluble CD40 ligand. Values are mean Ϯ standard deviation.
both sCD40L and IL-18 exhibit no correlation with hs-CRP-associated inflammatory pathway, as other investigators have previously suggested. 10 -16,25-29 Although IL-18 was negatively associated with HDL levels, confirming previous data, 29 the similar values of the latter inflammatory mediator and sCD40L in the microalbuminuric and the normoalbuminuric group could be attributed partially to the rather non-high lipid profile observed in both groups. 14 -16,27-29 Consequently, both sCD40L and IL-18 could mirror more progressed inflammatory and atherosclerotic involvement than hs-CRP and MA, in this clinical setting. Moreover, our results support the notion that MA could be considered as an index of endothelial dysfunction and low-grade inflammation, at least of the cascade reflected by augmented plasma levels of hs-CRP. 1, [17] [18] [19] [20] Taking this hypothesis even further, we may propose that in the vicious circle connecting essential hypertension, microalbuminuric state, and atherosclerotic cardiovascular events, apart from the mainstay role of both the renin-angiotensin-aldosterone system and endothelial dysfunction, subclinical inflammation participates through different pathways to all stages of this deleterious process. 1,18 -20,25,26,30 From a clinical point of view, ACR determination in this setting may ameliorate cardiovascular risk stratification by identifying patients with a cluster of modifiable risk factors, who might benefit from early intervention. Models that include hs-CRP and ACR may predict cardiovascular events in a more accurate way than those models with only hs-CRP. In contrast, measurement of IL-18 and sCD40L at this stage of essential hypertension may be of no additional clinical value, because they may identify a inflammatory and atherogenic milieu, distinct from that associated with early stages of essential hypertension and MA. 10 -16,18 -20,25,27-29 These speculations should be considered with the potential limitations of the study, such as, the small number of the participants, the single measurements of IL-18 and sCD40L, and the established effect of BP status on both ACR and proinflammatory processes. 20, 25, 30 Patients with cardiovascular risk factors that affect significantly the levels of ACR and inflammatory markers, such as smoking, obesity, and diabetes mellitus were excluded, limiting the generalization and the cost effectiveness of the study. Furthermore, because the genders differ with respect to prevalence and clinical implications of MA and subclinical inflammation, 1,2,8,10 -16 the fact that only male subjects participated in our cohort, renders important the confirmation of our findings by using female hypertensives.
In conclusion, MA is accompanied by increased levels of hs-CRP, but not by augmented IL-18 and sCD40L concentrations in essential hypertensive patients. These novel findings, although needing further validation, may support the notion of the activation of different inflammatory pathways in the progression of renal and cardiovascular atherosclerotic disease. Abbreviations as in Table 2 .
